Pharmacogenomics & Precision Psychiatry: Conference Sessions

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• SymposiumFrom Evidence to Practice: 2026 Update on Pharmacogenetic Guidance for the Child and Adolescent Psychiatric Provider

  Lisa B. Namerow · Salma Malik · Jeffrey Robert Strawn · Laura B. Ramsey · Jeffrey R. Bishop

  Annual update on pharmacogenetic testing guidance for pediatric psychiatric prescribing, from clinician-researchers including Jeffrey Strawn, Laura Ramsey, and Jeffrey Bishop.

  Child & Adolescent

• LectureFocus on Clinically Relevant Pharmacokinetic and Pharmacodynamic Genes

  Salma Malik

  Reviews the pharmacokinetic and pharmacodynamic genes most relevant to prescribing psychotropic medications for children and adolescents.

  Child & AdolescentDrug Interactions & Safety

• LectureRecent Pharmacogenetic Data With a Focus on Antipsychotic Medications

  Laura B. Ramsey

  Presents recent pharmacogenetic findings relating to antipsychotic medications in young patients.

  Antipsychotic PrescribingChild & Adolescent

• LectureFollowing the Evidence: Guidelines and Resources to Inform the Use of Pharmacogenomics in Antipsychotic Prescribing

  Jeffrey R. Bishop

  Covers available guidelines and resources that help clinicians apply pharmacogenomic information when prescribing antipsychotics.

  Antipsychotic PrescribingChild & Adolescent

• LectureIntegrating Pharmacogenetics Into Clinical Care

  Lisa B. Namerow

  Discusses practical approaches to incorporating pharmacogenetic testing into routine child and adolescent psychiatric care.

  Child & Adolescent

See all 20 pharmacogenomics & precision psychiatry sessions at this meeting →

APNA 40th Annual Conference

October 28–31, 2026 · Phoenix, AZ

• LectureThe Precision Mental Health Frontier: Are You Ready to Bridge the Gap?

  Nicole Perez · Rose Mary Xavier

  Foundation for integrating genomics and precision-health concepts into person-centered psychiatric nursing practice.

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• PosterLatent Psychiatric Subtypes and Treatment Outcomes in Opioid Use Disorder: A Secondary Analysis of CTN-0094

  Tobias Atkin

  Secondary analysis of psychiatric subtypes and OUD treatment outcomes.

  Opioid Use Disorder

NPA 32nd Annual Psychopharmacology Update 2027

February 10–13, 2027 · Las Vegas, NV

• LecturePharmacogenomics and Psychiatry

  Dan Roden

  What pharmacogenomic testing can and cannot tell us when selecting and dosing psychotropics.

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• LectureE01 – Targeting the immune pathogenesis for the development of novel diagnostics and therapeutics of affective and non-affective psychosis

  Paolo Enrico · Rachel Upthegrove

  Educational update on immune-molecular patient stratification and multimodal inflammation measures in early psychosis.

  Inflammation & ImmunopsychiatrySchizophrenia & Psychosis

• SymposiumS04 – Updates on bipolar disorder research: advancing translation into clinical practice

  Galila Agam · Olav B Smeland · Frank Bellivier · Caterina del Mar Bonnin Roig

  Sex differences, genomics, lithium-response prediction (R-LiNK), and cognitive resilience in bipolar disorder.

  Bipolar DisorderLithium & Mood Stabilizers

• SymposiumS05 – Biomarker-based prediction and stratification in ADHD – where do we stand?

  Cristine Marie Yde Ohki · Carmen Schiweck · Barbara Franke · Marta Ribasés

  Microbiota metabolites, inflammation, epigenetics, and polygenic risk as candidate stratification biomarkers in ADHD.

  ADHDInflammation & Immunopsychiatry

• SymposiumMS02 – Proof-of-concept studies showcasing biomarker potential

  Leanne Williams · Daniel Gehrlach

  Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.

  DepressionDrug Pipeline & Clinical Trials

• CourseCS02 – ECNP Child & Adolescent Psychiatry Course Session – from evidence-based care to precision approaches

  Hilgo Bruining · Gonzalo Salazar de Pablo

  Interactive course on evidence-based and precision approaches to child and adolescent psychiatry and neurodevelopmental disorders.

  Autism & Neurodevelopmental DisordersChild & Adolescent

See all 7 pharmacogenomics & precision psychiatry sessions at this meeting →

WCP 2026 — 26th World Congress of Psychiatry

September 23–26, 2026 · Stockholm, Sweden

• CourseCourse 09: Inflammatory Signatures and Somatic Comorbidity in Psychiatry: Foundations for Precision Immunopsychiatry

  Angelo Halaris · Janet Cunningham

  Course on inflammation-based markers and somatic comorbidity as a basis for precision immunopsychiatry.

  Inflammation & ImmunopsychiatryMedical Comorbidity & C-L Psychiatry

• SymposiumPrecision Psychiatry Advances in the Biological Understanding and Clinical Management of Mood Disorders

  Bipolar DisorderDepression

• LectureDistinguished Lectures: Ethics, Cognition, and Genomic Frameworks in Contemporary Psychiatry

  Practice, Policy & Workforce

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA

• LectureInflammatory and Immune-Driven Depression: CRP, Biomarkers, and Anti-Inflammatory Treatment Pathways

  Charles Raison

  Reviews the inflammatory depression phenotype and CRP-guided antidepressant selection, plus anti-inflammatory, glutamatergic, microbiome, and lifestyle interventions targeting immune activity.

  DepressionInflammation & ImmunopsychiatryLifestyle & Integrative Psychiatry